PharmaCyte Biotech, Inc. — All Filings
460 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
4
424B2
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
PRE 14A
PREC14A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10QSB | — | 0000939802-04-000121 | Mar 15, 2004 | Jan 31, 2004 |
| 10QSB | — | 0000939802-03-000425 | Dec 15, 2003 | Oct 31, 2003 |
| 10QSB | — | 0000939802-03-000307 | Aug 26, 2003 | Jul 31, 2003 |
| 10QSB | — | 0000939802-03-000177 | May 28, 2003 | Jan 31, 2003 |
| 10KSB | — | 0000939802-03-000180 | May 28, 2003 | Apr 30, 2003 |
| SB-2/A | — | 0000939802-03-000028 | Feb 4, 2003 | — |
| SB-2/A | AMENDMENT NO. 3 | 0000939802-02-000454 | Dec 11, 2002 | — |
| SB-2/A | — | 0000939802-02-000129 | Apr 24, 2002 | — |
| SB-2/A | SB-2/A | 0000912057-02-002342 | Jan 23, 2002 | — |
| SB-2 | SB-2 | 0000912057-01-529570 | Aug 20, 2001 | — |